Vir Biotechnology, INC Form 4 insider transactions

Director Farid Ramy acquired 16,000 shares of common stock and stock options in Vir Biotechnology on May 29, 2024.

Director Norbert W. Bischofberger acquired 16,000 shares of common stock and stock options in Vir Biotechnology, Inc. on May 29, 2024.

Marianne De Backer, CEO of Vir Biotechnology, sold 72,995 shares of common stock on April 3, 2024, to cover tax obligations related to vesting restricted stock units.

Ann M. Hanly, EVP & Chief Technology Officer of Vir Biotechnology, sold 2,711 shares of common stock on April 1, 2024, to cover tax obligations related to vesting restricted stock units.

Sung Lee, EVP & Chief Financial Officer of Vir Biotechnology, sold 6,008 shares of common stock on March 27, 2024, to cover tax withholding obligations related to vesting restricted stock units.